Pharmacology British Journal of Pharmacology

PAR2 and TRPV4 channel team up to break nasal barrier in dust mite allergy

  • In dust mite allergic rhinitis, nasal epithelium shows raised PAR2 and TRPV4; PAR2 tracked with barrier proteins in a small exploratory patient subgroup.
  • In a Der p 1 epithelial model, blocking TRPV4 prevented PAR2-driven barrier loss, and a PKCε-calcium feedback loop sustained by TRPV4 residue Y110 was implicated.
  • PAR2 and TRPV4 antagonists were evaluated in mouse allergy models.
Points Based on the abstract

Weak synergy on co-activation undercuts the "team up" framing: if PAR2 and TRPV4 are merely additive, dual blockade may buy little over one arm. Epithelial culture with Der p 1 can't show that, and the claudin-1/ZO-1 link comes from a small exploratory subgroup, so it is correlation. Before choosing a target, I'd want single versus combined antagonists in the mouse models, with TRPV4 Y110 mutants as a specificity control.